PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365A959. A total of 3 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,520 | -52.8% | 2,000 | -33.3% | 0.00% | – |
| Q4 2023 | $5,340 | +3.8% | 3,000 | -3.2% | 0.00% | – |
| Q3 2023 | $5,146 | -79.4% | 3,100 | -75.2% | 0.00% | – |
| Q2 2023 | $25,000 | +1884.1% | 12,500 | +1983.3% | 0.00% | – |
| Q1 2023 | $1,260 | -86.3% | 600 | -91.0% | 0.00% | – |
| Q4 2022 | $9,179 | -60.1% | 6,700 | -69.7% | 0.00% | – |
| Q3 2022 | $23,000 | -46.5% | 22,100 | -44.6% | 0.00% | – |
| Q2 2022 | $43,000 | 0.0% | 39,900 | -1.5% | 0.00% | – |
| Q1 2022 | $43,000 | -91.7% | 40,500 | -93.5% | 0.00% | – |
| Q4 2021 | $521,000 | +53.2% | 626,200 | +144.8% | 0.00% | – |
| Q3 2021 | $340,000 | -43.3% | 255,800 | -18.5% | 0.00% | -100.0% |
| Q2 2021 | $600,000 | +1478.9% | 313,900 | +3592.9% | 0.00% | – |
| Q1 2021 | $38,000 | +31.0% | 8,500 | +7.6% | 0.00% | – |
| Q4 2020 | $29,000 | +222.2% | 7,900 | +216.0% | 0.00% | – |
| Q2 2020 | $9,000 | +50.0% | 2,500 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 400 | $0 | 0.00% |
| GROUP ONE TRADING LLC | 600 | $1,260 | 0.00% |